Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Jan;11(1):41-4.
doi: 10.1111/j.1463-1326.2008.00988.x.

The rapid-acting properties of insulin aspart are preserved in elderly people with type 2 diabetes

R Krones  1 , C Schütte, T Heise
Affiliations
Randomized Controlled Trial

The rapid-acting properties of insulin aspart are preserved in elderly people with type 2 diabetes

R Krones et al. Diabetes Obes Metab. 2009 Jan.

Abstract

Aims: Elderly type 2 diabetes patients may face increased risk of hypoglycaemic episodes because of unpredictable eating habits. The pharmacokinetics and pharmacodynamics of insulin aspart (IAsp) were studied in elderly patients to examine the potential for postprandial dosing.

Methods: Nineteen type 2 diabetes subjects, aged > or =65 years, were enrolled in this randomized, double-blind, crossover trial. Subjects received 0.3 U/kg IAsp or regular human insulin during a glucose clamp procedure.

Results: IAsp showed a faster onset of action with significantly higher values for area under the glucose infusion rate curves, AUC(GIR(0-120 min)) and AUC(GIR(0-300 min)) (p = 0.0001). Maximum metabolic activity was higher (4.4 vs. 3.8 mg/kg/min, p = 0.0039) and occurred earlier with IAsp (196 vs. 278 min, p < 0.0001). Late metabolic activity (AUC(GIR (300-600 min))) was significantly lower with IAsp (p = 0.0006).

Conclusion: Clinical studies are required to confirm whether postprandial administration of IAsp is appropriate for elderly patients.

PubMed Disclaimer

Publication types

MeSH terms